Neurosense Therapeutics Ltd. (NRSN) traded at $0.77 in after-hours, marking a 10% increase from its regular session close of $0.70. * This significant movement follows the disclosure of insider buying, with CEO Alon Ben-Noon and CFO Or Eisenberg each acquiring 250,000 ordinary shares on June 16, 2026. * The shares were purchased at $0.80 per share in a private placement, signaling strong confidence from the company's leadership.